Literature DB >> 3743154

The safety of outpatient transbronchial biopsy.

M Ahmad, D R Livingston, J A Golish, A C Mehta, H P Wiedemann.   

Abstract

Fiberoptic bronchoscopy (FOB) is an accepted outpatient procedure, but transbronchial biopsy (TBB) is generally reserved for hospitalized patients. Over a three-year period, we performed fluoroscopically guided TBB in 148 of 688 outpatients undergoing FOB. Following the procedure, fluoroscopy was used to screen for possible pneumothorax in those patients who had had TBB. All patients were observed for one hour and then discharged if stable. Three patients (2.02 percent) were admitted and observed for acute hemoptysis following TBB. Bleeding ceased spontaneously in each. The remaining 145 patients were discharged after one hour of observation. One patient (0.68 percent) required Heimlich tube treatment for a delayed pneumothorax. Our experience indicates a low incidence of delayed complications in patients who are asymptomatic for one hour following TBB. We conclude that patients do not require hospitalization solely for TBB.

Entities:  

Mesh:

Year:  1986        PMID: 3743154     DOI: 10.1378/chest.90.3.403

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  11 in total

1.  British Thoracic Society guidelines on diagnostic flexible bronchoscopy.

Authors: 
Journal:  Thorax       Date:  2001-03       Impact factor: 9.139

Review 2.  The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction.

Authors: 
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

3.  Utility of Bronchoalveolar Lavage and Transbronchial Biopsy in Patients with Hypersensitivity Pneumonitis.

Authors:  Traci N Adams; Chad A Newton; Kiran Batra; Muhanned Abu-Hijleh; Tyonn Barbera; Jose Torrealba; Craig S Glazer
Journal:  Lung       Date:  2018-06-29       Impact factor: 2.584

Review 4.  Pneumothorax after transbronchial needle biopsy.

Authors:  Tatjana Boskovic; Milos Stojanovic; Jelena Stanic; Slobodanka Pena Karan; Gordana Vujasinovic; Dragan Dragisic; Konstantinos Zarogoulidis; Ioanna Kougioumtzi; Georgios Dryllis; Ioannis Kioumis; Georgia Pitsiou; Nikolaos Machairiotis; Nikolaos Katsikogiannis; Antonis Papaiwannou; Athanasios Madesis; Konstantinos Diplaris; Theodoros Karaiskos; Bojan Zaric; Perin Branislav; Paul Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

5.  Pneumothorax After Transbronchial Biopsy in Pulmonary Fibrosis: Lessons from the Multicenter COMET Trial.

Authors:  Jonathan A Galli; Nicholas L Panetta; Nathaniel Gaeckle; Fernando J Martinez; Bethany Moore; Thomas Moore; Anthony Courey; Kevin Flaherty; Gerard J Criner
Journal:  Lung       Date:  2017-06-16       Impact factor: 2.584

6.  Transbronchial biopsy without fluoroscopy: a five year experience in outpatients.

Authors:  O de Fenoyl; F Capron; B Lebeau; J Rochemaure
Journal:  Thorax       Date:  1989-11       Impact factor: 9.139

7.  Indications for performing flexible bronchoscopy: Trends over 34 years at a tertiary care hospital.

Authors:  Ankit Amar Gupta; Inderpaul Singh Sehgal; Sahajal Dhooria; Navneet Singh; Ashutosh Nath Aggarwal; Dheeraj Gupta; Digambar Behera; Ritesh Agarwal
Journal:  Lung India       Date:  2015 May-Jun

Review 8.  Complications and discomfort of bronchoscopy: a systematic review.

Authors:  Elise Orvedal Leiten; Einar Marius Hjellestad Martinsen; Per Sigvald Bakke; Tomas Mikal Lind Eagan; Rune Grønseth
Journal:  Eur Clin Respir J       Date:  2016-11-11

Review 9.  Iatrogenic bleeding during flexible bronchoscopy: risk factors, prophylactic measures and management.

Authors:  Maurizio Bernasconi; Coenraad F N Koegelenberg; Angela Koutsokera; Adam Ogna; Alessio Casutt; Laurent Nicod; Alban Lovis
Journal:  ERJ Open Res       Date:  2017-06-21

10.  Aspergillus-PCR in bronchoalveolar lavage for detection of invasive pulmonary aspergillosis in immunocompromised patients.

Authors:  Michael Buess; Gieri Cathomas; Jörg Halter; Lilian Junker; Peter Grendelmeier; Michael Tamm; Daiana Stolz
Journal:  BMC Infect Dis       Date:  2012-10-02       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.